The expression of microRNA-451 in human endometriotic lesions is inversely related to that ofmacrophage migration inhibitory factor (MIF) and regulates MIF expression and modulation of epithelial cell survival

Human Reproduction

Volumn 30, Issue 3, 2015, Pages 642-652

  Graham, Amanda ^a,b   Falcone, Tommaso ^c   Nothnick, Warren B ^a,b  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Endometriosis; Macrophage migration inhibitory factor; miRNA

Indexed keywords

CYCLIN E; DOCUSATE SODIUM; ETHINYLESTRADIOL PLUS NORGESTIMATE; FLUOXETINE; HYDROMORPHONE; IBUPROFEN; LORATADINE; MACROPHAGE MIGRATION INHIBITION FACTOR; MECLOFENAMIC ACID; MESSENGER RNA; MICRORNA; MICRORNA 451; MULTIVITAMIN; NAPROXEN; OXYBUTYNIN; OXYCODONE PLUS PARACETAMOL; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PREDNISONE; PROMETHAZINE; RANITIDINE; UNCLASSIFIED DRUG; CCNE1 PROTEIN, HUMAN; MIRN451 MICRORNA, HUMAN; ONCOPROTEIN; PTEN PROTEIN, HUMAN;

3' UNTRANSLATED REGION; ADULT; ARTICLE; CELL PROLIFERATION; CELL SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENDOMETRIOSIS; ENDOMETRIUM; ENDOMETRIUM BIOPSY; EPITHELIUM CELL; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; PROTEIN EXPRESSION; WESTERN BLOTTING; YOUNG ADULT; CELL CULTURE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PHYSIOLOGY;

ADULT; CELL SURVIVAL; CELLS, CULTURED; CYCLIN E; ENDOMETRIOSIS; FEMALE; GENE EXPRESSION REGULATION; HUMANS; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MICRORNAS; ONCOGENE PROTEINS; PTEN PHOSPHOHYDROLASE; RNA, MESSENGER;

EID: 84935089687     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/dev005     Document Type: Article

References (48)

1. Akoum A, Kong J, Metz C, Beaumont MC. Spontaneous and stimulated secretion of monocyte chemotactic protein-1 and macrophage migration inhibitory factor by peritoneal macrophages in women with and without endometriosis. Fertil Steril 2002;77:989-994.
2. Altinoz MA, Korkmaz R. NF-kappaB, macrophage migration inhibitory factor and cyclooxygenase-inhibitions as likely mechanisms behind the acetaminophen-and NSAID-prevention of the ovarian cancer. Neoplasma 2004;51:239-247.
3. Arcuri F, Ricci C, Ietta F, Cintorino M, Tripodi SA, Cetin I, Garzia E, Schatz F, Klemi P, Santopietro R et al. Macrophage migration inhibitory factor in the human endometrium: expression and localization during the menstrual cycle and early pregnancy. Biol Reprod 2001;64:1200-1205.
4. Asare Y, Schmitt M, Bernhagen J. The vascular biology of macrophage migration inhibitory factor (MIF). Expression and effects in inflammation, atherogenesis and angiogenesis. Thromb Haemost 2013;109:391-398.
5. Ashcroft GS, Mills SJ, Lei K, Gibbons L, Jeong MJ, Taniguchi M, Burow M, Horan MA, Wahl SM, Nakayama T. Estrogen modulates cutaneous wound healing by downregulating macrophage migration inhibitory factor. J Clin Invest 2003;111:1309-1318.
6. Bandres E, Bitarte N, Arias F, Agorreta J, Fortes P, Agirre X, Zarate R, Diaz-Gonzalez JA, Ramirez N, Sola JJ et al. Micro RNA-451 regulates macrophage migration inhibitory factor production and proliferation of gastrointestinal cancer cells. Clin Cancer Res 2009;15:2281-2290.
7. Bartel DP. Micro RNAs: genomics, biogenesis, mechanism, and function. Cell 2004;116:281-297.
8. Bergamaschi A, Katzenellenbogen BS. Tamoxifen downregulation of miR-451 increases 14-3-3z and promotes breast cancer cell survival and endocrine resistance. Oncogene 2012;31:39-47.
9. Braza-Böils A, Maŕi-Alexandre J, Gilabert J, Sánchez-Izquierdo D, España F, Estellés A, Gilabert-Estellés J. Micro RNA expression profile in endometriosis: its relation to angiogenesis and fibrinolytic factors. Hum Reprod 2014;29:978-988.
10. Canis M, Donnez JG, Guzick DS, Halme JK, Rock JA, Schenken RS, Vernon MW. Revised American Society for Reproductive Medicine classification of endometriosis: 1996. Fertil Steril 1997;67:817-821.
11. Carli C, Metz CN, Al-Abed Y, Naccache PH, Akoum A. Up-regulation of cyclooxygenase-2 expression and prostaglandin E2 production in human endometriotic cells by macrophage migration inhibitory factor: involvement of novel kinase signaling pathways. Endocrinology 2009; 150:3128-3137.
12. Erson AE, Petty EM. Micro RNAs in development and disease. Clin Genet 2008;74:296-306.
13. Filigheddu N, Gregnanin I, Proporato PE, Surico D, Perego B, Galli L, Patrignani C, Graziani A, Surico N. Differential expression of microRNAs between eutopic and ectopic endometrium in ovarian endometriosis. J Biomed Biotechnol 2010;369549.
14. Giudice LC, Kao LC. Endometriosis. Lancet 2004;364:1789-1799.
15. Halme J, Hammond MG, Hulka JF, Raj SG, Talbert LM. Retrograde menstruation in healthy women and in patients with endometriosis. Obstet Gynecol 1984;64:151-154.
16. Hawkins SM, Creighton CJ, Han DY, Zariff A, Anderson ML, Gunaratne PH, Matzuk MM. Functional Mirco RNA involved in endometriosis. Mol Endocrinol 2011;25:821-832.
17. Houdeau E, Moriez R, Leveque M, Salvador-Cartier C, Waget A, Leng L, Bueno L, Bucala R, Fioramonti J. Sex steroid regulation of macrophage migration inhibitory factor in normal and inflamed colon in the female rat. Gastroenterology 2007;132:982-993.
18. Howell RJ, Dowsett M, Edmonds DK. Oestrogen and progesterone receptors in endometriosis: heterogeneity of different sites. Hum Reprod 1994;9:1752-1758.
19. Kats R, Collette T, Metz CN, Akoum A. Marked elevation of macrophage migration inhibitory factor in the peritoneal fluid of women with endometriosis. Fertil Steril 2002a;78:69-76.
20. Kats R, Metz CN, Akoum A. Macrophage migration inhibitory factor is markedly expressed in active and early-stage endometriotic lesions. J Clin Endocrinol Metab 2002b;87:883-889.
21. Kats R, Al-Akoum M, Guay S, Metz C, Akoum A. Cycle-dependent expression of macrophage migration inhibitory factor in the human endometrium. Hum Reprod 2005;20:3518-3525.
22. Khoufache K, Bazin S, Girard K, Guillemette J, Roy MC, Verreault JP, Al-Abed Y, Foster W, Akoum A. Macrophage migration inhibitory factor antagonist blocks the development of endometriosis in vivo. PLoS One 2012;7:e37264.
23. Kniss DA, Zimmerman PD, Garver CL, Fertel RH. Interleukin-1 receptor antagonist blocks interleukin-1-induced expression of cyclooxygenase-2 in endometrium. Am J Obstet Gynecol 1997;177:559-567.
24. Liu DTY, Hitchcock A. Endometriosis: Its association with retrograde menstruation, dysmenorrhea, and tubal pathology. Br J Obstet Gynaecol 1986;93:859-886.
25. Liu N, Jiang N, Guo R, Jiang W, He QM, Xu YF, Li YZ, Tang LL, Mao YP, Sun Y et al. Mi R-451 inhibits cell growth and invasion by targeting MIF and is associated with survival in nasopharyngeal carcinoma. Mol Cancer 2013; 12:123.
26. Liu D, Liu C, Wang X, Ingvarsson S, Chen H. Micro RNA-451 suppresses tumor growth by down-regulating IL6R gene expression. Cancer Epidemiol 2014a;38:85-92.
27. Liu X, Zhang X, Xiang J, Lv Y, Shi J. miR-451: potential role as tumor suppressor of human hepatoma cell growth and invasion. Int J Oncol 2014b;45:739-745.
28. Lv G, Hu Z, Tie Y, Du J, Fu H, Gao X, Zheng X. Micro RNA-451 regulates activating transcription factor 2 expression and inhibits liver cancer cell migration. Oncol Rep 2014;32:1021-1028.
29. Morin M, Bellehumeur C, Therriault MJ, Metz C, Maheux R, Akoum A. Elevated levels of macrophage migration inhibitory factor in the peripheral blood of women with endometriosis. Fertil Steril 2005;83:865-872.
30. Murata K, Yoshitomi H, Furu M, Ishikawa M, Shibuya H, Ito H, Matsuda S. Micro RNA-451 down-regulates neutrophil chemotaxis via p38 MAPK. Arthritis Rheumatol 2014;66:549-559.
31. Musil R, Schwarz MJ, Riedel M, Dehning S, Cerovecki A, Spellmann I, Arolt V, Müller N. Elevated macrophage migration inhibitory factor and decreased transforming growth factor-beta levels in major depression-no influence of celecoxib treatment. J Affect Disord 2011;134:217-225.
32. Nakayama N, Nakayama K, Shaimima Y, Ishikawa M, Katagiri A, Iida K, Miyazaki K. Gene amplification CCNE1 is related to poor survival and potential therapeutictargetinovarian cancer. Cancer 2010;116:2621-2634.
33. Nan Y, Han L, Zhang A, Wang G, Jia Z, Yang Y, Yue X, Pu P, Zhong Y, Kang C. Mi RNA-451 plays a role as tumor suppressor in human glioma cells. Brain Res 2010;1359:14-21.
34. Nothnick WB, Healy CA. Estrogen induces distinct patterns of microRNA expression within the mouse uterus. Reprod Sci 2010;17:987-994.
35. Nothnick WB, Colvin A, Cheng KF, Al-Abed Y. The macrophage migration inhibitory factor antagonist, ISO-1 suppresses endometriotic lesion size in mice with experimentally induced disease. J Endometr 2011;3:135-142.
36. Nothnick WB, Graham A, Holbert J, Weiss MJ. miR-451 deficiency is associated with altered endometrial fibrinogen alpha chain expression and reduced endometriotic lesion establishment in an experimental mouse model. PLoS One 2014;9:e100336.
37. Ohkawara T, Takeda H, Ohnishi S, Kato M, Nishihira J, Asaka M. Macrophage migration inhibitory factor contributes to development of nonsteroidal anti-inflammatory drugs-induced gastric injury in mice. Int Immunopharmacol 2011;11:418-423.
38. Ohlsson Teague EM, Van der Hoek KH, Van der Hoek MB, Perry N, Wagaarachchi P, Robertson SA, Print CG, Hull LM. Micro RNA-regulated pathways associated with endometriosis. Mol Endocrinol 2009; 23:265-275.
39. Pan Q, Luo X, Toloubeydokhti T, Chegini N. The expression profile of micro-RNA in endometrium and endometriosis and the influence of ovarian steroids on their expression. Mol Hum Reprod 2007;13:797-806.
40. Rosenberger CM, Podyminogin RL, Navarro G, Zhao GW, Askovich PS, Weiss MJ, Aderem A. miR-451 regulates dendritic cell cytokine responses to influenza infection. J Immunol 2012;189:5965-5975.
41. Vasudevan S, Tong Y, Steitz JA. Switching from repression to activation: microRNAs can up-regulate translation. Science 2007;318:1931-1934.
42. Veillat V, Carli C, Metz CN, Al-Abed Y, Naccache PH, Akoum A. Macrophage migration inhibitory factor elicits an angiogenic phenotype in human ectopic endometrial cells and triggers the production of major angiogenic factors via CD44, CD74, and MAPK signaling pathways. J Clin Endocrinol Metab 2010;95:403-412.
43. Wang R, Wang ZX, Yang JS, Pan X, De W, Chen LB. Micro RNA-451 functions as a tumor suppressor in human non-small cell lung cancer by targeting ras-related protein 14 (RAB14). Oncogene 2011;30: 2644-2658.
44. Xia HH, Zhang ST, Lam SK, Lin MC, Kung HF, Wong BC. Expression of macrophage migration inhibitory factor in esophageal squamous cell carcinoma and effects of bile acids and NSAIDs. Carcinogenesis 2005; 26:11-15.
45. Yang Y, Degranpré P, Kharfi A, Akoum A. Identification of macrophage migration inhibitory factor as a potent endothelial cell growth-promoting agent released by ectopic human endometrial cells. J Clin Endocrinol Metab 2000;85:4721-4727.
46. Yin Y, Shen WH. PTEN: a new guardian of the genome. Oncogene 2008; 27:5443-5453.
47. Zhang X, Wang X, Zhu H, Zhu C, Wang Y, Pu WT, Jegga AG, Fan G-C. Synergistic effect of the GATA-4-mediated miR-144/451 cluster in protection against simulated ischemia/reperfusion-induced cardiomyocyte death. J Mol Cell Cardiol 2010;49:841-850.
48. Zhang Y, Zhang M, Zhong M, Suo Q, Lv K. Expression profilesof miRNAs in polarized macrophages. Int J Mol Med 2013;31:797-802.